These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5858728)

  • 41. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. XIV. THE ORGANIZATION OF CONTROL VACCINATIONS AND THE EVALUATION OF COMPARATIVE PROPERTIES OF INDIVIDUAL GROUPS VACCINATED WITH DIFFERENT STRAINS].
    KOSTRZEWSKI J; PLACHCINSKA J
    Przegl Epidemiol; 1963; 17():99-109. PubMed ID: 14053748
    [No Abstract]   [Full Text] [Related]  

  • 42. [Protective vaccinations in prevention of acute infectious diseases in Poland in 1918-1923].
    Wieckowska E
    Przegl Epidemiol; 1999; 53(3-4):395-401. PubMed ID: 10800579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of the attenuated oral vaccine strain "S. typhi" Ty 21a.
    Germanier R; Fürer E
    Dev Biol Stand; 1983; 53():3-7. PubMed ID: 6873472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of the reference preparation for the determination of relative potency of typhoid vaccines].
    Rabczyńska F
    Przegl Epidemiol; 1968; 22(1):71-8. PubMed ID: 5669177
    [No Abstract]   [Full Text] [Related]  

  • 45. [New vaccinations--indications and effect].
    Stickl H
    Med Welt; 1983 Sep; 34(39):1081-4. PubMed ID: 6645887
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antigen Vi content in typhoid vaccines used for epidemiologic experiments in the USSR in 1961].
    Taylor A; Bencjanowa TG
    Przegl Epidemiol; 1968; 22(1):57-69. PubMed ID: 5669176
    [No Abstract]   [Full Text] [Related]  

  • 47. [Protective vaccinations in children with severe allergic reactions].
    Berek-Pyzikowa B
    Przegl Epidemiol; 1969; 23(1):135-8. PubMed ID: 5790101
    [No Abstract]   [Full Text] [Related]  

  • 48. Vaccination against typhoid fever in travellers: a cost-effectiveness approach.
    Papadimitropoulos V; Vergidis PI; Bliziotis I; Falagas ME
    Clin Microbiol Infect; 2004 Aug; 10(8):681-3. PubMed ID: 15301670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Apropos of antityphoid vaccination].
    MOULIS A
    Toulouse Med; 1963; 64():623-4. PubMed ID: 13936308
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative evaluation of reactogenic properties and effectiveness of vaccines for the prevention of typhoid and paratyphoid B infections. (Principal data on an epidemiological survey in 1962)].
    Kheifets LB; Salmin LV; Leitman MZ; Kuz'minova ML; Vasil'eva AV; Slavina AM; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Jul; 42(7):58-65. PubMed ID: 5884186
    [No Abstract]   [Full Text] [Related]  

  • 51. COMPARATIVE EVALUATION OF TYPHOID VACCINES PREPARED BY VARIOUS METHODS.
    KHEIFETS LB; SALMIN LV; LEITMAN MZ; KUZMINOVA ML; VASILEVA AV; GALPERIN IP; SLAVINA AM; ZHDANOVA LD; PLETNEVA OG; VARSANOVA EY; GINZBURG GM; GLYAZER NG; MELNIK EY
    Fed Proc Transl Suppl; 1965; 24():27-30. PubMed ID: 14275825
    [No Abstract]   [Full Text] [Related]  

  • 52. [Combined (associated) immunization against typhoid, typhus and plague].
    Gapochko KG; Misnikov OP; Kolkov VF; Kekcheeva NG; Semenova BN; Titova TS
    Voen Med Zh; 1994 Apr; (4):42-6, 79. PubMed ID: 8091696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ENHANCED SEROLOGIC RESPONSE OF LEPROMATOUS PATIENTS TO ANTITYPHOID VACCINATION.
    OLIVEIRADEALMEIDA J; BRANDAO H; GARCIADELIMA E
    Int J Lepr; 1964; 32():292-6. PubMed ID: 14227403
    [No Abstract]   [Full Text] [Related]  

  • 54. [Contribution to the study of physiopathology of the preventive antityphoid-paratyphoid vaccination. I. Effects of the administration of T. A. B. vaccine on the clinical, hematological and blood protein pictures].
    Del Campo A; Zardini V
    Riv Ital Ig; 1965; 25(3):261-81. PubMed ID: 5883807
    [No Abstract]   [Full Text] [Related]  

  • 55. An optimization model for reducing typhoid cases in developing countries without increasing public spending.
    Lauria DT; Maskery B; Poulos C; Whittington D
    Vaccine; 2009 Mar; 27(10):1609-21. PubMed ID: 19146902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Why are typhoid vaccines not recommended for epidemic typhoid fever?
    Taylor DN; Levine MM; Kuppens L; Ivanoff B
    J Infect Dis; 1999 Dec; 180(6):2089-90. PubMed ID: 10558978
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experimental study of controlled release microencapsulated Salmonella typhi capsular polysaccharide vaccines immunized mice].
    Yang C; Yan R; Zeng W; Zhang Y; Jia W; Liu J; Zhou S; Li X; Deng X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):626-9. PubMed ID: 14716862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Volunteer studies in the development of a live oral typhoid vaccine.
    Dima VF
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):191-8. PubMed ID: 6673697
    [No Abstract]   [Full Text] [Related]  

  • 59. [Vaccination against diarrheal diseases and typhoid fever. Current status and prospects].
    Ivanoff B; Neira M
    Ann Med Interne (Paris); 1998 Oct; 149(6):340-50. PubMed ID: 9853044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of tetanus toxoid administered by intradermal route in association with typhoid vaccine.
    Dimache G; Croitoru M; Ciordaş C; Stoean C; Durbacă S; Macovei A; Bălută MM
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):61-9. PubMed ID: 6529361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.